Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy

We introduce and demonstrate use of a novel, diffuse optical tomography (DOT) based breast cancer signature for monitoring progression of neoadjuvant chemotherapy. This signature, called probability of malignancy, is obtained by statistical image analysis of total hemoglobin concentration, blood oxy...

Descripción completa

Detalles Bibliográficos
Autores principales: Busch, David R., Choe, Regine, Rosen, Mark A., Guo, Wensheng, Durduran, Turgut, Feldman, Michael D., Mies, Carolyn, Czerniecki, Brian J., Tchou, Julia, DeMichele, Angela, Schnall, Mitchell D., Yodh, Arjun G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Optical Society of America 2012
Materias:
Optics in Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539198/
https://www.ncbi.nlm.nih.gov/pubmed/23304651
http://dx.doi.org/10.1364/BOE.4.000105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539198/
https://www.ncbi.nlm.nih.gov/pubmed/23304651
http://dx.doi.org/10.1364/BOE.4.000105

Ejemplares similares